Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kerala Ayurveda Ltd has informed the stock exchange that its Board of Directors, at a meeting held on May 26, 2025, reviewed and amended the company's 'Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information' (UPSI) as required under Regulation 8(2) of SEBI's Insider Trading Regulations, 2015. The amended code, which covers definitions of designated persons, connected persons, legitimate purposes for sharing sensitive information, digital database maintenance, and disclosure protocols, has been uploaded to the company's investor relations webpage. The filing is signed by Priyanka Gangwar, Company Secretary and Compliance Officer. No financial figures or business-specific data are mentioned — this is purely a policy and compliance-related disclosure.
This is a routine regulatory compliance update with no direct impact on the company's financials, operations, or stock price. It reflects the company staying current with SEBI's insider trading framework and ensures stronger governance around handling of price-sensitive information.